Paper41346243
Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells.
Prestegui-Martel B and 6 others. Nanomedicine (Lond), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells. Papers, record 41346243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41346243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Trypanosoma cruzi | Major topic |
| Oligonucleotides, Antisense | Major topic |
| Calreticulin | Major topic |
| Nanoparticles | Major topic |
| Chagas Disease | Major topic |
| Animals | |
| Humans | |
| Protozoan Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SECIHTI | PubMed | |||
| UNAM-PAPIIT | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32356888 | Phosphorothioate modified oligonucleotide-protein interactions. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32356888 | PubMed |
| 2 | 15385491 | A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. | Infect Immun | 2004 | https://conductscience.org/library/papers/15385491 | PubMed |
| 3 | 24551259 | A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24551259 | PubMed |
| 4 | 18657458 | Calcineurin B of the human protozoan parasite Trypanosoma cruzi is involved in cell invasion. | Microbes Infect | 2008 | https://conductscience.org/library/papers/18657458 | PubMed |
| 5 | 29367754 | Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. | Sci Rep | 2018 | https://conductscience.org/library/papers/29367754 | PubMed |
| 6 | 10233151 | Trypanosoma cruzi calreticulin is a lectin that binds monoglucosylated oligosaccharides but not protein moieties of glycoproteins. | Mol Biol Cell | 1999 | https://conductscience.org/library/papers/10233151 | PubMed |
| 7 | 33633318 | Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. | Sci Rep | 2021 | https://conductscience.org/library/papers/33633318 | PubMed |
| 8 | 33006041 | Differential gene expression of virulence factors modulates infectivity of TcI Trypanosoma cruzi strains. | Parasitol Res | 2020 | https://conductscience.org/library/papers/33006041 | PubMed |
| 9 | 20472323 | Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. | Immunobiology | 2011 | https://conductscience.org/library/papers/20472323 | PubMed |
| 10 | 31437457 | The effects of endoplasmic reticulum stressors, tunicamycin and dithiothreitol on Trypanosoma cruzi. | Exp Cell Res | 2019 | https://conductscience.org/library/papers/31437457 | PubMed |
| 11 | 35327448 | Calreticulin Regulates β1-Integrin mRNA Stability in PC-3 Prostate Cancer Cells. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327448 | PubMed |
| 12 | 22954747 | Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis. | Mol Immunol | 2013 | https://conductscience.org/library/papers/22954747 | PubMed |
| 13 | 25150720 | Design and self-assembly of simple coat proteins for artificial viruses. | Nat Nanotechnol | 2014 | https://conductscience.org/library/papers/25150720 | PubMed |
| 14 | 30131175 | Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression. | Immunobiology | 2018 | https://conductscience.org/library/papers/30131175 | PubMed |
| 15 | 30831156 | Proteomic analysis of glycosomes from Trypanosoma cruzi epimastigotes. | Mol Biochem Parasitol | 2019 | https://conductscience.org/library/papers/30831156 | PubMed |
| 16 | 28437166 | Virus-Like Particles of mRNA with Artificial Minimal Coat Proteins: Particle Formation, Stability, and Transfection Efficiency. | Nucleic Acid Ther | 2017 | https://conductscience.org/library/papers/28437166 | PubMed |
| 17 | 22808206 | Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection. | PLoS One | 2012 | https://conductscience.org/library/papers/22808206 | PubMed |
| 18 | 18512343 | Trypanosoma cruzi: parasite and host cell signaling during the invasion process. | Subcell Biochem | 2008 | https://conductscience.org/library/papers/18512343 | PubMed |
| 19 | 35271563 | Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021. | MMWR Morb Mortal Wkly Rep | 2022 | https://conductscience.org/library/papers/35271563 | PubMed |
| 20 | 32896515 | Optimization and application of MTT assay in determining density of suspension cells. | Anal Biochem | 2020 | https://conductscience.org/library/papers/32896515 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41346243
GET https://conductscience.org/api/papers/v1/41346243/references?page=2